Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

CODX holding history

Co-Diagnostics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CODX overviewAll 13F holders of CODXFull Q2 2026 holdings

Shares (Q2 2026)
16,091
Value
$49.9K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of CODX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,091$49.9K<0.1%+8,723+118.4%AddedHolders
Q1 20267,368$13.7K<0.1%−24,086−76.6%ReducedHolders
Q4 202531,454$5.32K<0.1%−86,790−73.4%ReducedHolders
Q3 2025118,244$40.7K<0.1%+116,992+9,344.4%AddedHolders
Q2 20251,252$351<0.1%−6,296−83.4%ReducedHolders
Q1 20257,548$2.34K<0.1%+5,835+340.6%AddedHolders
Q4 20241,713$1.28K<0.1%−11,060−86.6%ReducedHolders
Q3 202412,773$16.0K<0.1%−9,770−43.3%ReducedHolders
Q2 202422,543$28.2K<0.1%+19,652+679.8%AddedHolders
Q1 20242,891$3.24K<0.1%−6,462−69.1%ReducedHolders
Q4 20239,353$12.4K<0.1%+9,253+9,253.0%AddedHolders
Q3 2023100$106<0.1%−1,141−91.9%ReducedHolders
Q2 20231,241$1.38K<0.1%−4,173−77.1%ReducedHolders
Q1 20235,414$8.01K<0.1%+1,045+23.9%AddedHolders
Q4 20224,369$11.0K<0.1%−4,122−48.5%ReducedHolders
Q3 20228,491$27.0K<0.1%+8,491NewHolders
Q2 20220$00.0%−1,500−100.0%Sold outHolders
Q1 20221,500$9.00K<0.1%−24,776−94.3%ReducedHolders
Q4 202126,276$235.0K<0.1%+9,560+57.2%AddedHolders
Q3 202116,716$163.0K<0.1%−13,760−45.2%ReducedHolders
Q2 202130,476$251.0K<0.1%−7,075−18.8%ReducedHolders
Q1 202137,551$358.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.